Clinical trials in dementia with propentofylline

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 307-316

  Kittner, Barbara ^a   Rössner, Martin ^a   Rother, Matthias ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROPENTOFYLLINE;

AGED; ALZHEIMER DISEASE; ANOREXIA; ASTHENIA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIINFARCT DEMENTIA; NAUSEA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; VASODILATATION; VERTIGO; VOMITING;

EID: 0030668582     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48481.x     Document Type: Conference Paper

References (15)

1. BOWEN, D. M. & A. N. DAVISON. 1986. Can the pathophysiology of dementia lead to rational therapy? In Treatment Development Strategies for Alzheimer's Disease. T. Crook, R. Bartus, S. Ferris & S. Gershon, Eds.: 36-66. Mark Powley. Madison, CT.
2. BANATI, R. B. et al. 1993. Cytotoxicity of microglia Glia 7: 111-118.
3. SCHUBERT, P., T. OGATA, K. RUDOLPHI, C. MARCHINI & A. MCRAE. 1997. Support of homeostatic glial cell signaling: A novel therapeutic approach by propentofylline. Ann. N. Y. Acad. Sci. This volume.
4. MÖLLER, H. J., I. MAURER & B. SALETU. 1994. Placebo-controlled trial of the xanthine derivative HWA 285 in dementia. Pharmacopsychiatry 27/4: 159-165.
5. AMERICAN PSYCHOLOGICAL ASSOCIATION. 1987. Diagnostic and Statistical Manual of Mental Disorders (3rd Revised edit.) DSM-III-R. American Psychiatric Association. Washington, D.C. pp. 97-126.
6. FOLSTEIN, M. F., S. E. FOLSTEIN & P. R. MCHUGH. 1975. "Mini-mental state": A practical method for grading the cognitive state of patients for clinician. J. Psychiatr. Res. 12: 189-198.
7. HACHINSKI, V. C., L. D. ILIFF, M. PHIL, E. ZILHKA, G. H. DU BOULAY, V. L. MCALLISTER et at. 1975. Cerebral blood flow in dementia. Arch. Neurol. 32: 632-637.
8. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, R. KATZMAN, D. PRICE & E. M. STANDLAN. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-949.
9. ROMAN, G. C., T. K. TATEMICHI, T. ERKINJUNTTI, J. L. CUMMINGS, J. C. MASDEU, J. H. GARCIA et al. 1993. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
10. GOTTRIES, C. G., G. BRÅNE, B. GULLBERG & G. STEEN. 1982. A new rating scale for dementia syndromes. Arch. Gerontol. Geriatr. 1: 311-330.
11. ASSOCIATION FOR METHODOLOGY AND DOCUMENTATION OF PSYCHOLOGY AND COLLEGIUM INTERNATIONALE (Psychiatriae Scalarum), Eds. 1990. Clinical Global Impressions. In Rating Scales for Psychiatry. Beltz Test GmbH. Weinheim, FRG.
12. ERZIGKEIT, H. SKT Manual. A short cognitive performance test for assessing memory and attention. (SKT manual published by Geromed GmbH, Europaplatz 14, 44575 Castrop-Rauxel, Germany.)
13. ROSEN, W. G., R. C. MOHS & K. DAVIS. 1989. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 141(11): 1356-1363.
14. OVERALL, J. E. & R. SCHALTENBRAND. 1992. The SKT neuropsychological test battery. J. Geriat. Psychiatr. Neurol. 5: 220-227.
15. FLEISCHMANN, U. M. & W. D. OSWALD. 1986. Nürnberger-Alters-Inventar (NAI) Kurzmanual: Testbeschreibung, Testkriterien, Normwerte. Universität Erlangen-Nürnberg. Nürnberg, Germany